Early Alzheimer's & Cognitive Decline

Early Alzheimer's and cognitive decline are increasingly understood not as a single inevitable disease, but as a protective brain response to multiple insults — metabolic, toxic, inflammatory, and infectious. Dr. Dale Bredesen, a neurologist and researcher whose work has redefined how we approach cognitive decline, has demonstrated that Alzheimer's is not only preventable but, in its early stages, reversible.

For decades, conventional medicine treated Alzheimer's as a hopeless, progressive death sentence — a single disease driven by amyloid plaques, with no meaningful treatment beyond symptom management. But Dr. Bredesen's research, beginning with his landmark 2014 paper documenting the first documented reversal of cognitive decline, proved that this model is fundamentally wrong. Alzheimer's is not one disease. It is a network response — the brain's attempt to protect itself when it is under sustained attack from multiple sources. When you identify and remove those sources, the brain can begin to recover.

Dr. Bredesen identified at least six major subtypes of cognitive decline, each with different root causes. Type 1 is inflammatory — driven by chronic systemic inflammation, often from the gut, infections, or poor diet. Type 1.5 is glycotoxic — driven by insulin resistance and blood sugar dysregulation, earning Alzheimer's the name "Type 3 Diabetes." The brain is an insulin-sensitive organ, and when insulin signaling fails in the brain, neurons starve for energy and begin to die. Type 2 is atrophic — driven by nutrient and hormone deficiencies, where the brain simply lacks the raw materials it needs to maintain and repair itself. Type 3 is toxic — driven by exposure to mycotoxins (mold), heavy metals, glyphosate, and other environmental toxins that directly damage neurons and disrupt cellular function. Type 4 is vascular — driven by reduced blood flow to the brain from cardiovascular disease, hypertension, or microvascular damage. Type 5 is trauma-related — driven by physical head trauma or repetitive concussions that initiate a cascade of neuroinflammation and degeneration.

The link between Alzheimer's and diet is profound. The Standard American Diet — high in refined sugars, processed seed oils, and chemical additives — directly drives insulin resistance, systemic inflammation, and gut dysbiosis, all of which feed cognitive decline. Glyphosate, the herbicide sprayed on GMO crops, has been shown to disrupt the gut-brain axis, chelate essential minerals, and promote inflammation in the brain. Ultra-processed foods contain additives and preservatives that cross the blood-brain barrier and accumulate in neural tissue. A ketogenic or low-glycemic diet, by contrast, provides the brain with ketones — an alternative, cleaner fuel source that neurons can use even when glucose metabolism is impaired.

The connection to infections is increasingly clear. Chronic Lyme disease and co-infections can drive neuroinflammation and produce symptoms that mimic or accelerate cognitive decline. Herpes simplex virus (HSV-1) has been found within amyloid plaques. Epstein-Barr and other latent viruses can reactivate and contribute to neurodegeneration. Chronic sinus and dental infections create ongoing inflammatory burden. P. gingivalis, the bacteria responsible for gum disease, has been found in the brains of Alzheimer's patients. Each of these infections adds fuel to the inflammatory fire that drives cognitive decline.

Toxins play a central role. Mold illness (CIRS) from water-damaged buildings produces mycotoxins that directly damage neurons and disrupt the blood-brain barrier. Heavy metals — mercury from dental amalgams and fish, lead from old pipes and paint, aluminum from cookware and antiperspirants — accumulate in the brain and promote oxidative damage. Glyphosate and other pesticides disrupt mitochondrial function and the gut microbiome. These toxic burdens, combined with genetic susceptibilities in detoxification pathways (MTHFR, GST, etc.), create a perfect storm for cognitive decline.

The good news — and this is what makes early Alzheimer's fundamentally different from the conventional narrative — is that it is stoppable and, in many cases, reversible. Dr. Bredesen's ReCODE protocol (Reversal of Cognitive Decline) is a personalized, multi-targeted approach that addresses all of the identified contributors simultaneously. It includes a ketogenic or low-glycemic diet, eliminating inflammatory and toxic foods, optimizing sleep and stress, targeted supplementation based on lab findings, hormone optimization, detoxification, treating underlying infections, and brain training. The protocol has documented cases of patients reversing from MCI (mild cognitive impairment) back to normal cognition, and even patients with moderate Alzheimer's showing significant improvement.

Apollo Health, Dr. Bredesen's organization, provides access to certified ReCODE practitioners who can guide patients through this comprehensive protocol. The key is early intervention — the earlier the root causes are identified and addressed, the greater the potential for reversal. Waiting until moderate or severe stages significantly reduces the window for recovery.

If you or a loved one is experiencing memory loss, brain fog, or early cognitive decline, do not accept "it's just aging" as an answer. Cognitive decline is not a normal part of aging — it is a signal that the brain is under attack. The causes can be found, and the decline can be stopped. You can find practitioners who understand the Bredesen approach and functional cognitive health here.